verywellhealth5h
A New 'Missile' Drug Is Approved To Treat the Most Common Breast Cancer Type
The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
NPR Illinois5h
Illinois lawmakers try again to ban certain food additives
Democratic Sen. Willie Preston, center, speaks at a Statehouse news conference Wednesday, Feb. 5, 2025, about his bill to ban ...
'Got to be extra responsible': Kona Ice removing harmful dyes to better protect kids
The company eliminated the dye back in 2013 and already offered 10 dye-free versions of its flavors. Recently, they added ...
Hosted on MSN11h
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay
The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...
Experimental vaccine seems to battle advanced kidney cancers
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...
Trump faces pressure from US industry over China tariff on medicines
President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new ...
healthday16h
Therapeutic Vaccine May Fight Advanced Kidney Cancer
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...
MedCity News19h
“Precision Med Has Evolved as Badly As I Expected” And Other Takeaways From Former FDA Commissioner At PMWC
Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in ...